Kymanox

Kymanox

Biotechnology

Morrisville, North Carolina 7,505 followers

Your Life Science Solutions Partner - Bio | Pharma | Device | Combo ...because patients deserve better

About us

Kymanox (‘ki-mah-noks’), meaning Ideal Knowledge Transfer, advances life science innovation through insightful solutions and collaboration. We do this by accelerating the design and commercialization of modern medicines for our customers using integrated engineering, scientific, compliance, and project management solutions that are insightful, collaborative, and comprehensive. By building and supporting the development of modern medicines, Kymanox has proven, end-to-end solutions that are helping bring better Life Science Products to the market- and keep it there. We do all of this with heart and pride… because patients deserve better. Kymanox, founded in 2004, serves clients from Fortune 100 companies to virtual start-up companies all across the globe. Headquartered in Research Triangle Park, NC, we have US offices in Boston and Philadelphia, and since 2022 have expanded to Germany, Switzerland, and Israel.

Industry
Biotechnology
Company size
201-500 employees
Headquarters
Morrisville, North Carolina
Type
Privately Held
Founded
2004
Specialties
Technical Project Management, Process Operations, Engineering, Commissioning and Validation, Training, FDA PAI Assistance, Sustainability, Combination Products, Tech Transfer, Human Factors, Packaging, Quality Control, CMC Services, Product Development, MS&T, Supply Chain, Clinical Affairs, Regulatory, Medical Affairs, Microbiology & Environmental Monitoring, Audit, and Compliance

Locations

Employees at Kymanox

Updates

  • View organization page for Kymanox, graphic

    7,505 followers

    We are thrilled to announce that this year's recipient of the Stepping Up: Emerging Leader Sage Award is Matthew Nordberg! This award recognizes an associate or mid-level employee who demonstrates emerging leadership abilities. Matthew's proactive approach, strategic decision-making, and ability to inspire those around him have been invaluable to our organization. As Wilma M. wisely stated, "Every single person has leadership ability. Some step up and take them. Some don't. My answer was to step up and lead." Matthew has embodied this sentiment, stepping up to drive results and guide his team to new heights of success. Please join us in congratulating Matthew on receiving the Stepping Up: Emerging Leader Sage Award!

    • No alternative text description for this image
  • View organization page for Kymanox, graphic

    7,505 followers

    Let us guide you to your next approval. Navigating complex regulatory pathways can be challenging. Kymanox understands the intricacies of identifying the optimal regulatory pathway, we’re here to support you through the process and set you up for success. Connect with us early to leverage our expertise in regulatory strategy and health authority interactions. Together, we’ll ensure your product is approved in an ever changing regulatory landscape. Talk to an expert: Erica Fadool | Scott Zawko | Crystal Spinks | Mitchel Kevern, MEM | Nathan B. --------- 𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐭𝐚𝐲 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐊𝐲𝐦𝐚𝐧𝐨𝐱: Follow Us: https://lnkd.in/e35y_dQq Get in Touch: www.kymanox.com Subscribe: https://lnkd.in/eYDXYarv

    • No alternative text description for this image
  • View organization page for Kymanox, graphic

    7,505 followers

    Kymanox is expanding its team! We're seeking talented professionals for multiple positions across #engineering, #quality, and #regulatory roles. Join Kymanox in making a difference in modern medicine through our commitment to quality, integrity, and gratitude...because patients deserve better! 🌐 𝐆𝐥𝐨𝐛𝐚𝐥 𝐑𝐞𝐚𝐜𝐡: We have offices worldwide, located throughout the United States and Europe. 𝐓𝐚𝐠 𝐬𝐨𝐦𝐞𝐨𝐧𝐞 𝐰𝐡𝐨 𝐦𝐢𝐠𝐡𝐭 𝐛𝐞 𝐢𝐧𝐭𝐞𝐫𝐞𝐬𝐭𝐞𝐝. Visit our career page to see our full listings and apply: https://lnkd.in/gwHfq_Jq #hiring --------- 𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐭𝐚𝐲 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐊𝐲𝐦𝐚𝐧𝐨𝐱: Follow Us: https://lnkd.in/e35y_dQq Get in Touch: www.kymanox.com Subscribe: https://lnkd.in/eYDXYarv

    • No alternative text description for this image
  • View organization page for Kymanox, graphic

    7,505 followers

    Join Kymanox at the Generis American Pharma Manufacturing & Outsourcing Summit! We are proud to be a featured speaker at the #USPharma24 in Boston, where top pharmaceutical leaders gather to drive forward manufacturing excellence and outsourcing optimization. Mark your calendar for 18 -19 November at The Westin Copley Place! 𝐕𝐢𝐬𝐢𝐭 𝐨𝐮𝐫 𝐛𝐨𝐨𝐭𝐡: Meet the Kymanox team, Chris Adkins and Nathan B., at booth #19 to discuss solutions for your manufacturing and outsourcing needs. 𝐅𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐑𝐨𝐮𝐧𝐝𝐭𝐚𝐛𝐥𝐞 (Day 1, 12:40 PM - 1:40 PM): Join our Executive Advisor, William Monteith, as he leads a Lunch & Learn on “Use of Outsourced Services in your Journey to Commercialization.” Dive into strategies for effective partnerships, project management, and facility readiness acceleration. This event promises strategic insights, expert-led presentations, and valuable networking opportunities with over 150 industry professionals. Book a meeting with our team onsite: https://lnkd.in/eNm7Y9wC --------- 𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐭𝐚𝐲 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐊𝐲𝐦𝐚𝐧𝐨𝐱: Follow Us: https://lnkd.in/e35y_dQq Get in Touch: www.kymanox.com Subscribe: https://lnkd.in/eYDXYarv

    • No alternative text description for this image
  • View organization page for Kymanox, graphic

    7,505 followers

    At Kymanox, we’re not just colleagues — we’re a community of passionate, dedicated individuals who work together to make a difference… because patients deserve better. Join me in welcoming our newest team members: Kayla Stellick | Neeraj Chandra Mishra | Robert Standifer | Sian Eden | Matthew May, MS | Deepthi Ragipani | Paul Ignotavich | José P. | Suzanne Mesko. Each brings unique talent, fresh ideas, and a shared commitment to our mission. Together, we’re building a workplace that values growth, creativity, and collaboration. Life at Kymanox is not all work. Thank you to all who participated in our Halloween Costume Contest! 🎃 A special shoutout to the winners:  #1 Eleven Katy Rommel, PhD, #2 Kronk Matthew May, and #3 Phantom of the Opera Kevin C. Brown, PMP! Thank you for adding a little extra magic and creativity to Kymanox! --------- 𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐭𝐚𝐲 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐊𝐲𝐦𝐚𝐧𝐨𝐱: Follow Us: https://lnkd.in/e35y_dQq Get in Touch: www.kymanox.com Subscribe: https://lnkd.in/eYDXYarv

  • View organization page for Kymanox, graphic

    7,505 followers

    This Veterans Day, we honor and express our deepest gratitude to the approximately 16 million military veterans who have courageously served our country. At Kymanox, we are especially grateful for the sacrifices made by veterans and their families, and we deeply appreciate their dedication, resilience, and commitment to our nation. To all veterans, thank you for your service and for all you've given. We honor you today and always. #VeteransDay

    • No alternative text description for this image
  • View organization page for Kymanox, graphic

    7,505 followers

    We are excited to announce that this year's recipient of the Next Level Support: Get'er DONE Sage Award is Bradley Price! This award recognizes an individual who pulls out all the stops to get the job done. Our winner consistently demonstrates extraordinary determination and resourcefulness in achieving results, no matter the challenge. As Rory Vaden wisely said, "Creating the next level of results requires the next level of thinking." Our recipient embodies this philosophy, going above and beyond to deliver exceptional outcomes. Please join us in congratulating Bradley Price on receiving the Next Level Support: Get'er DONE Sage Award!

    • No alternative text description for this image
  • View organization page for Kymanox, graphic

    7,505 followers

    Last night was truly a recipe for magic! ✨ We’re thrilled to share that Kymanox ranked #35 in the 2024 Triangle Business Journal Fast 50 Awards! Being part of this prestigious list of the Triangle’s fastest-growing companies is an honor, and last night, we felt like winners surrounded by colleagues and friends who make it all possible. The evening was filled with joy, inspiration, and a bit of sparkle as we celebrated alongside incredible innovators from our region. Thank you to Triangle Business Journal for a memorable night, and congratulations to all of the amazing companies recognized this year! Check out a few moments from the evening below!

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
      +1
  • View organization page for Kymanox, graphic

    7,505 followers

    Last week we released our episode, How #RNA Origami is Revolutionizing Drug Development, featuring David Harrell, CEO of Helixomer, and Ryan M. Doxey, Senior Director of Technical Services at Kymanox. This episode has quickly become a favorite as it dives into the technical details behind RNA technology and how it can be utilized for structural purposes in drug development. David and Ryan explore how RNA origami creates precise, foldable structures, allowing for targeted drug delivery and intricate protein interactions—all without altering the genome. This innovative approach is reshaping possibilities for precision medicine and more adaptable therapies. Don’t miss out on the future of RNA in healthcare—catch up on the latest episode of The Factor! --------- 𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐭𝐚𝐲 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐊𝐲𝐦𝐚𝐧𝐨𝐱: Follow Us: https://lnkd.in/e35y_dQq Get in Touch: www.kymanox.com Subscribe: https://lnkd.in/eYDXYarv

  • View organization page for Kymanox, graphic

    7,505 followers

    𝐈𝐂𝐘𝐌𝐈: GLP-1 therapies are transforming healthcare. They offer promising advancements in treating obesity and related conditions. In the October 2024 issue of ONdrugDelivery, Kymanox CEO Stephen M. Perry participated in a roundtable discussion alongside Mathias Romacker, Kymanox Executive Advisor, and Andreas Schneider, Head of Innovation at Ypsomed AG. Together, they explored the future of GLP-1s and their potential to revolutionize care for a wide range of health issues. Read the full interview for insights on the disruptive impact of GLP-1 therapies and the challenges of scaling innovative delivery solutions. https://lnkd.in/e4Hrth-n Interview with: Guy Furness --------- 𝐖𝐚𝐧𝐭 𝐭𝐨 𝐬𝐭𝐚𝐲 𝐜𝐨𝐧𝐧𝐞𝐜𝐭𝐞𝐝 𝐰𝐢𝐭𝐡 𝐊𝐲𝐦𝐚𝐧𝐨𝐱: Follow Us: https://lnkd.in/e35y_dQq Get in Touch: www.kymanox.com Subscribe: https://lnkd.in/eYDXYarv

Similar pages

Browse jobs

Funding

Kymanox 2 total rounds

Last Round

Debt financing
See more info on crunchbase